Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens <i>in vitro</i> and <i>in vivo</i>.

Front Chem · 2018 · PMC6102830 · PMID 30155456

Europe PMC DOI

hedged sentence

0.5300

closest p · 10.6× alpha

0.5300

boldest claim

The sentences

did not reach statistical significancep = 0.53not close (p > 0.1)

While survival seemed improved (40% for imipenem alone and 80% with the addition of A3-APO), the difference in survival did not reach statistical significance ( p = 0.53).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.